Literature DB >> 20468049

Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats.

L H Shen1, Y Li, M Chopp.   

Abstract

Bone marrow stromal cells (BMSCs) facilitate functional recovery in rats after focal ischemic attack. Growing evidence suggests that the secretion of various bioactive factors underlies BMSCs' beneficial effects. This study investigates the expression of glial cell derived neurotrophic factor (GDNF) in the ischemic hemisphere with or without BMSC administration. Adult male Wistar rats were subjected to 2 h of middle cerebral artery occlusion followed by an injection of 3 x 10(6) BMSCs (n = 11) or phosphate-buffered saline (n = 10) into the tail vein 24 h later. Animals were sacrificed seven days later. Single and double immunohistochemical staining was performed to measure GDNF, Ki67, doublecortin, and glial fibrillary acidic protein expression as well as the number of apoptotic cells along the ischemic boundary zone (IBZ) and/or in the subventricular zone (SVZ). BMSC treatment significantly increased GDNF expression and decreased the number of apoptotic cells in the IBZ (P < 0.05). GDNF expression was colocalized with GFAP. Meanwhile, BMSCs increased the number of Ki-67 positive cells and the density of DCX positive migrating neuroblasts (P < 0.05). GDNF expression was significantly increased in single astrocytes collected from animals treated with BMSCs, and in astrocytes cocultured with BMSCs after OGD (P < 0.05). Our data suggest that BMSCs increase GDNF levels in the ischemic hemisphere; the major source of GDNF protein is reactive astrocytes. We propose that the increase of GDNF in response to BMSC administration creates a hospitable environment for local cellular repair as well as for migrating neuroblasts from the SVZ, and thus contributes to the functional improvement. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20468049      PMCID: PMC3096459          DOI: 10.1002/glia.20988

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  48 in total

1.  Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.

Authors:  S P Dormady; O Bashayan; R Dougherty; X M Zhang; R S Basch
Journal:  J Hematother Stem Cell Res       Date:  2001-02

Review 2.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

3.  Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?

Authors:  F Villars; L Bordenave; R Bareille; J Amédée
Journal:  J Cell Biochem       Date:  2000-09-14       Impact factor: 4.429

4.  Adult bone marrow transplantation after stroke in adult rats.

Authors:  Y Li; J Chen; M Chopp
Journal:  Cell Transplant       Date:  2001 Jan-Feb       Impact factor: 4.064

5.  Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis.

Authors:  K Hamano; T S Li; T Kobayashi; S Kobayashi; M Matsuzaki; K Esato
Journal:  Cell Transplant       Date:  2000 May-Jun       Impact factor: 4.064

6.  Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain.

Authors:  A Arvidsson; Z Kokaia; M S Airaksinen; M Saarma; O Lindvall
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

7.  Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice.

Authors:  D M Hermann; E Kilic; S Kügler; S Isenmann; M Bähr
Journal:  Neurobiol Dis       Date:  2001-08       Impact factor: 5.996

8.  Dynamic expression of glial cell line-derived neurotrophic factor after cerebral ischemia.

Authors:  G Wei; G Wu; X Cao
Journal:  Neuroreport       Date:  2000-04-27       Impact factor: 1.837

9.  Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat.

Authors:  W R Zhang; T Hayashi; M Iwai; I Nagano; K Sato; Y Manabe; K Abe
Journal:  Brain Res       Date:  2001-06-08       Impact factor: 3.252

10.  Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; Z Zhang; D Lu; M Lu; M Chopp
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

View more
  36 in total

Review 1.  Injury and repair in the neurovascular unit.

Authors:  Changhong Xing; Kazuhide Hayakawa; Josephine Lok; Ken Arai; Eng H Lo
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

Review 2.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

3.  Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Kazuyuki Saito; Masa-aki Abe; Toshihiko Maeda; Hiroyo Haruki; Takashi Kanda
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

4.  Fimbria-fornix (FF)-transected hippocampal extracts induce the activation of astrocytes in vitro.

Authors:  Linqing Zou; Haoming Li; Guohua Jin; Meiling Tian; Jianbing Qin; Heyan Zhao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-11-08       Impact factor: 2.416

Review 5.  Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation.

Authors:  Dirk M Hermann; Michael Chopp
Journal:  Lancet Neurol       Date:  2012-03-19       Impact factor: 44.182

6.  New expression of 5-HT1A receptor in astrocytes in the gerbil hippocampal CA1 region following transient global cerebral ischemia.

Authors:  Choong Hyun Lee; Ji Hyeon Ahn; Moo-Ho Won
Journal:  Neurol Sci       Date:  2014-09-25       Impact factor: 3.307

7.  Efficient Generation of Functionally Active Spinal Cord Neurons from Spermatogonial Stem Cells.

Authors:  Hao Yang; Cuicui Liu; Bo Chen; Jing An; Rui Zhang; Qian Zhang; Jingjing Zhao; Baorong He; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2016-08-26       Impact factor: 5.590

Review 8.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

9.  Intravascular stem cell transplantation for stroke.

Authors:  Angela M Auriat; Sahar Rosenblum; Tenille N Smith; Raphael Guzman
Journal:  Transl Stroke Res       Date:  2011-08-04       Impact factor: 6.829

10.  Treatment with Mesenchymal-Derived Extracellular Vesicles Reduces Injury-Related Pathology in Pyramidal Neurons of Monkey Perilesional Ventral Premotor Cortex.

Authors:  Maria Medalla; Wayne Chang; Samantha M Calderazzo; Veronica Go; Alexandra Tsolias; Joseph W Goodliffe; Dhruba Pathak; Diego De Alba; Monica Pessina; Douglas L Rosene; Benjamin Buller; Tara L Moore
Journal:  J Neurosci       Date:  2020-04-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.